NCT04964752View on ClinicalTrials.gov

A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes

NAUnknownINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

April 30, 2022

Conditions
Diabetes
Interventions
DEVICE

continuous glucose-monitoring

Continuous glucose-monitoring device indicated for continually recording interstitial fluid glucose levels in patients with diabetes.

Sponsors
All Listed Sponsors
collaborator

Powder (Guangzhou) Pharmaceuticals Limited

UNKNOWN

collaborator

Powder Pharmaceuticals (HK) Co., Ltd

UNKNOWN

lead

Lee's Pharmaceutical Limited

INDUSTRY

NCT04964752 - A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes | Biotech Hunter | Biotech Hunter